Patents by Inventor Martin Krüger

Martin Krüger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7864879
    Abstract: A system having a signal processor for detection of a signal type of a signal is disclosed. One embodiment includes a processor designed to determine a first variable which is characteristic of a first spectrum element of the signal spectrum, and to determine a second variable which is characteristic of a second spectrum element of the signal spectrum. A system is provided for determination of a ratio between the first variable and the second variable, and a detector which is designed to detect the signal type on the basis of the ratio.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: January 4, 2011
    Assignee: Infineon Technologies AG
    Inventors: Xiaofeng Wu, Martin Krueger
  • Patent number: 7847133
    Abstract: The invention relates to a process for preparing an alcoholic solution of an alkali metal alkoxide from alkali metal hydroxide and alcohol in a reaction column, the alcohol and the alkali metal hydroxide being conducted in countercurrent, which is characterized in that a reflux ratio of at least 0.05 is established in the reaction column.
    Type: Grant
    Filed: May 27, 2008
    Date of Patent: December 7, 2010
    Assignee: Evonik Degussa GmbH
    Inventors: Johannes Ruwwe, Kai-Martin Krüger, Udo Knippenberg, Volker Brehme, Manfred Neumann
  • Patent number: 7825128
    Abstract: The invention relates to sulfoximine-substituted pyrimidines of the general formula I processes for the preparation thereof and their use as drugs.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 2, 2010
    Assignee: Bayer Schering Pharma AG
    Inventors: Ulrich Lücking, Duy Nguyen, Arne Von Bonin, Oliver Von Ahsen, Martin Krüger, Hans Briem, Georg Kettschau, Olaf Prien, Anne Mengel, Krolikiewicz Konrad, Ulf Boemer, Ulrich Bothe, Ingo Hartung
  • Patent number: 7809053
    Abstract: A device for scaling and quantization of digital soft output values (sk) from an equalizer has a control loop for controlling a statistical parameter (?) for the scaled and quantized soft output values (sD,k), which contains a calculation unit (4) for calculation of the statistical parameter (?), and a control unit (5) for calculation of a scaling factor (c) for scaling the soft output values (sk) from the equalizer on the basis of the statistical parameter (?).
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: October 5, 2010
    Assignee: Infineon Technologies AG
    Inventor: Martin Krüger
  • Patent number: 7724021
    Abstract: The invention involves a programmable power supply device with configurable restrictions to the programmability of the power supply device, wherein the programmable power supply device comprises a number of freeze/programmability levels, each freeze/programmability defining a dedicated access restriction to the programmability of the power supply device.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: May 25, 2010
    Assignee: Infineon Technologies Austria AG
    Inventors: Martin Krueger, Erwin Huber, Jens Barrenscheen
  • Patent number: 7724836
    Abstract: In order to compensate for a frequency offset or a change in the phase of the transmission channel over time during mobile radio transmission of data symbols, the data symbols are transmitted by way of carrier-frequency, modulated data bursts. Sample values of the received signal, which are known in advance and correspond to first and second symbols, are evaluated in order to estimate the frequency offset or the change in the phase of the transmission channel over time. These first and second symbols are transmitted with a defined phase angle by way of the data burst, and are arranged separated from one another in the data burst. Edge symbols in a data burst are advantageously used as first and second symbols, or as a symbol pair, for estimation.
    Type: Grant
    Filed: September 7, 2004
    Date of Patent: May 25, 2010
    Assignee: Infineon Technologies AG
    Inventors: Ralf Hartmann, Martin Krüger, Hartmut Wilhelm
  • Publication number: 20100076000
    Abstract: This invention relates to pyrimidine derivatives of general formula I in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-receptor tyrosine kinases, their production as well as their use as medications for treatment of various diseases.
    Type: Application
    Filed: October 12, 2004
    Publication date: March 25, 2010
    Inventors: Ulrich Lücking, Martin Krüger, Rolf Jautelat, Gerhard Siemeister
  • Publication number: 20100045336
    Abstract: The invention involves a programmable power supply device with configurable restrictions to the programmability of the power supply device, wherein the programmable power supply device comprises a number of freeze/programmability levels, each freeze/programmability defining a dedicated access restriction to the programmability of the power supply device.
    Type: Application
    Filed: August 20, 2008
    Publication date: February 25, 2010
    Inventors: Martin Krueger, Erwin Huber, Jens Barrenscheen
  • Patent number: 7668977
    Abstract: A method for exchanging information between a first device and a second device connected via a communication link, the communication link supporting a query command and at least a further command, where each command includes a specific command code is described. The method comprises transmitting a query command code and data from the first device via the communication link, the data identifying a specific command, receiving the query command code and the data at the second device, transmitting reply data from the second device via the communication link, the reply data including at least a first segment and a second segment, and receiving the reply data at the first device, wherein the first segment includes information whether the specific command is supported, wherein, if the specific command is not supported, the second segment includes information identifying an alternative command to the specific command.
    Type: Grant
    Filed: September 12, 2007
    Date of Patent: February 23, 2010
    Assignee: Infineon Technologies Austria AG
    Inventors: Martin Krueger, Erwin Huber
  • Patent number: 7620100
    Abstract: In a method for equalization of a signal that is transmitted via a user channel using the DF method, an interference channel is taken into account by the DF contribution that is used for processing of the user channel trellis diagram containing information about the interference channel.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: November 17, 2009
    Assignee: Infineon Technologies AG
    Inventors: Burkhard Becker, Bertram Gunzelmann, Martin Krueger, Xiaofeng Wu
  • Publication number: 20090234980
    Abstract: A system and method for statistics recording of power devices is disclosed. A power circuit includes a power device to provide a specified electrical power to a load and a host controller coupled to the power device. The host controller is configured to provide issue instructions to and retrieve status information from the power device. A communications and control interface (CCI) is coupled between the power device and the host controller. The CCI is configured to operate as a communications interface between the power device and the host controller and to retrieve and store status information from the power device. The CCI may be capable of performing statistical analysis on the status information to help reduce the amount of information exchanged between the host controller and the power device, thereby reducing bandwidth requirements.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 17, 2009
    Inventors: Jens Barrenscheen, Giuseppe Bernacchia, Martin Krueger, Erwin Huber
  • Patent number: 7572794
    Abstract: The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
    Type: Grant
    Filed: November 3, 2005
    Date of Patent: August 11, 2009
    Assignee: Bayer Schering Pharma AG
    Inventors: Rolf Bohlmann, Martin Haberey, Andreas Huth, Stuart James Ince, Martin Krueger, Karl-Heinz Thierauch, Holger Hess-Stumpp
  • Publication number: 20090099219
    Abstract: The invention relates to alkynylpyrimidines according to the general formula (I): in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, and salts, N-oxides, metabolites, solvates, tautomers and prodrugs thereof, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.
    Type: Application
    Filed: June 19, 2008
    Publication date: April 16, 2009
    Inventors: Ingo Hartung, Ulrich Bothe, Georg Kettschau, Ulrich Luecking, Anne Mengel, Martin Krueger, Karl Heinz Thierauch, Philip Lienau, Ulf Boemer
  • Patent number: 7517894
    Abstract: VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: April 14, 2009
    Assignee: Bayer Schering Pharma AG
    Inventors: Andreas Huth, Ludwig Zorn, Martin Krueger, Stuart Ince, Karl Heinz Thierauch, Andreas Menrad, Martin Haberey, Holger Hess-Stumpp
  • Publication number: 20090070505
    Abstract: A method for exchanging information between a first device and a second device connected via a communication link, the communication link supporting a query command and at least a further command, where each command includes a specific command code is described. The method comprises transmitting a query command code and data from the first device via the communication link, the data identifying a specific command, receiving the query command code and the data at the second device, transmitting reply data from the second device via the communication link, the reply data including at least a first segment and a second segment, and receiving the reply data at the first device, wherein the first segment includes information whether the specific command is supported, wherein, if the specific command is not supported, the second segment includes information identifying an alternative command to the specific command.
    Type: Application
    Filed: September 12, 2007
    Publication date: March 12, 2009
    Inventors: Martin Krueger, Erwin Huber
  • Patent number: 7479491
    Abstract: The invention relates to substituted anthranylalkyl and -cycloalkyl amides of general formula (I) and to their use as medicaments for treating diseases caused by persistent angiogenesis.
    Type: Grant
    Filed: September 21, 2004
    Date of Patent: January 20, 2009
    Assignee: Novartis AG
    Inventors: Dieter Seidelmann, Martin Krueger, Eckhard Ottow, Andreas Huth, Karl-Heinz Thierauch, Andreas Menrad, Martin Haberey
  • Patent number: 7459470
    Abstract: Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: December 2, 2008
    Assignee: Schering AG
    Inventors: Alexander Ernst, Andreas Huth, Martin Krueger, Karl-Heniz Thierauch, Andreas Menrad, Martin Haberey
  • Patent number: 7429592
    Abstract: Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, such as, e.g., stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: September 30, 2008
    Assignee: Schering Aktienegesellschaft
    Inventors: Alexander Ernst, Andreas Huth, Martin Krueger, Karl-Heinz Thierauch, Andreas Menrad, Martin Haberey
  • Publication number: 20080219287
    Abstract: The invention is directed to a device for determining a number of data packets which are to be converted into a coded sequence with a predetermined number KN of bits by a coder. The device determines the number of data packets in such a manner that a difference between the resultant code rate RN, resulting from a conversion of the number of data packets into the coded sequence, and a reference code rate R1 does not exceed a predetermined threshold value.
    Type: Application
    Filed: July 13, 2007
    Publication date: September 11, 2008
    Inventors: Martin Krueger, Roland Gruber, Andre Zorn
  • Publication number: 20080181326
    Abstract: A transmitter is configured to transmit a transmit signal modulated according to a first modulation scheme, the first modulation scheme being associated with a set of first constellation points. The transmitter transmits at least a part of the transmit signal based on a subset of the first constellation points, wherein the subset of first constellation points approximates second constellation points of a set of second constellation points associated with a second modulation scheme. The first and second modulation schemes are different from one another.
    Type: Application
    Filed: January 23, 2008
    Publication date: July 31, 2008
    Applicant: Infineon Technologies AG
    Inventors: Martin Krueger, Holger Neuhaus, Burkhard Becker